Status Epilepticus — MCQs
In a status epilepticus patient, first-line drug is
The first step on priority basis required in the management of status epilepticus is
Intravenous anaesthetic agent of choice in status epilepticus
What is the drug of choice for managing status epilepticus?
Which of the following electrolyte abnormalities is a cause of status epilepticus in a child?
A pediatric patient presents with a 45-minute history of continuous convulsions. The senior resident (SR) recommends IV lorazepam, but the junior resident (JR) is unable to secure IV access. What is the next best step in management?
According to current AAP guidelines, which of the following scenarios would be considered a relative indication for continuous antiepileptic prophylaxis in febrile seizures (though still generally not recommended)?
Post-mortem caloricity is not seen in which of the following conditions?
Which is not used in status epilepticus?
Among the neurological manifestations, acute lead poisoning in children can present with:
Status Epilepticus Indian Medical PG Practice Questions and MCQs
Question 1: In a status epilepticus patient, first-line drug is
- A. Phenytoin
- B. Magnesium
- C. Benzodiazepine (Correct Answer)
- D. Barbiturates
Explanation: ***Benzodiazepine*** - **Benzodiazepines** are the first-line treatment for status epilepticus due to their rapid onset of action in enhancing **GABAergic inhibition** [1]. - They effectively terminate seizures by binding to **GABA-A receptors**, leading to increased chloride influx and neuronal hyperpolarization. *Phenytoin* - **Phenytoin** is a second-line antiepileptic drug that can be used if benzodiazepines are unsuccessful, but it is not the initial treatment [1]. - Its mechanism involves blocking **voltage-gated sodium channels** to stabilize neuronal membranes and prevent seizure propagation [2]. *Magnesium* - **Magnesium sulfate** is primarily used in status epilepticus caused by **eclampsia** or severe **hypomagnesemia**, not as a general first-line agent. - It acts by stabilizing neuronal excitability and reducing acetylcholine release at the neuromuscular junction. *Barbiturates* - **Barbiturates** (e.g., phenobarbital) are typically considered third-line agents for refractory status epilepticus due to their significant side effects, including **respiratory depression** and hypotension. - They potentiate **GABA-A receptor** activity, similar to benzodiazepines, but with a higher risk profile.
Question 2: The first step on priority basis required in the management of status epilepticus is
- A. i.v. Phenytoin
- B. i.v. Phenobarbitone
- C. Airway maintenance (Correct Answer)
- D. i.v. Diazepam
Explanation: ***Airway maintenance*** - Maintaining a **patent airway** is the absolute first step in any emergency, especially in status epilepticus where respiratory depression and aspiration risk are high [2]. - Ensuring adequate **oxygenation and ventilation** is critical for preventing brain hypoxia and further complications [1]. *i.v. Phenytoin* - While an important drug for the long-term management and prevention of recurrent seizures, **phenytoin** has a delayed onset of action and is not the first-line agent for acute seizure termination in status epilepticus. - It is typically administered after initial first-line agents like benzodiazepines have been given. *i.v. Phenobarbitone* - **Phenobarbitone** is a potent anticonvulsant and can be used in refractory status epilepticus, but it is not the very first step. - Its use often comes with significant **sedation and respiratory depression**, necessitating close airway monitoring. *i.v. Diazepam* - **Intravenous diazepam** is a rapid-acting benzodiazepine and is usually the first-line medication to **terminate acute seizures** in status epilepticus. - However, airway maintenance precedes even medication administration to ensure patient safety before drug effects take hold [1], [2].
Question 3: Intravenous anaesthetic agent of choice in status epilepticus
- A. Thiopentone
- B. Etomidate
- C. Ketamine
- D. Propofol (Correct Answer)
Explanation: ***Propofol*** - **Propofol** is favored due to its rapid onset and short duration of action, allowing for quick titration to seizure control and rapid assessment of neurological function post-seizure. - Its potent GABAergic effects effectively **suppress seizure activity** in refractory status epilepticus. *Thiopentone* - While effective in terminating seizures due to its potent GABAergic action, **thiopentone** has a much longer context-sensitive half-time, leading to prolonged sedation and delayed neurological assessment. - Its use often necessitates **intubation and mechanical ventilation** due to significant respiratory depression. *Etomidate* - **Etomidate** is a potent sedative that can terminate seizures but is strongly associated with **adrenal suppression** due to inhibition of 11-β-hydroxylase, which limits its use in status epilepticus, particularly with prolonged infusions. - It has a short duration of action but lacks the neuroprotective properties of other agents and can cause **myoclonus**, which might be confused with ongoing seizure activity. *Ketamine* - **Ketamine** primarily acts as an NMDA receptor antagonist and is often used in refractory status epilepticus that fails to respond to GABAergic drugs (benzodiazepines, propofol, barbiturates). - It is not considered the **first-line intravenous anesthetic agent of choice** and is typically reserved for later stages of management due to its different mechanism of action and potential side effects like hallucinations and cardiovascular stimulation.
Question 4: What is the drug of choice for managing status epilepticus?
- A. Propofol
- B. Thiopentone
- C. Phenytoin
- D. Lorazepam (Correct Answer)
Explanation: ***Lorazepam*** - **Lorazepam** is the preferred first-line agent for status epilepticus due to its rapid onset of action and relatively long duration of anticonvulsant effect (12-24 hours), making it highly effective in stopping ongoing seizures. - Its **lipophilicity** allows it to quickly cross the blood-brain barrier while having less redistribution than diazepam, providing sustained seizure control. - Dose: **0.1 mg/kg IV** (typically 4 mg) administered at 2 mg/min. *Propofol* - **Propofol** is an anesthetic agent used in **refractory status epilepticus** when first and second-line agents have failed. - It carries risks of **hemodynamic instability**, **propofol infusion syndrome** with prolonged use, and requires ICU monitoring with intubation. - Reserved for third-line therapy, not appropriate as initial management. *Thiopentone* - **Thiopentone** is a barbiturate used for **refractory status epilepticus** as a third-line agent. - It has a longer half-life and recovery time compared to benzodiazepines, with significant **cardiovascular depression** and respiratory suppression. - Requires ICU setting with mechanical ventilation and hemodynamic support. *Phenytoin* - **Phenytoin** (or fosphenytoin) is a **second-line agent** used after benzodiazepines if seizures persist. - It has a **slower onset of action** (15-30 minutes) compared to benzodiazepines and requires cardiac monitoring due to risk of arrhythmias. - Loading dose: **20 mg/kg IV** at maximum rate of 50 mg/min to avoid cardiovascular complications.
Question 5: Which of the following electrolyte abnormalities is a cause of status epilepticus in a child?
- A. Hypokalemia
- B. Hyperkalemia
- C. Hypernatremia
- D. Hyponatremia (Correct Answer)
Explanation: ***Hyponatremia*** - **Hyponatremia** (low sodium levels) can lead to **cerebral edema**, increasing intracranial pressure and predisposing to seizures, including status epilepticus, especially in children. - Rapid shifts in fluid balance and electrolyte disturbances, such as those seen with severe hyponatremia, can destabilize neuronal membranes and trigger **sustained seizure activity**. *Hypokalemia* - While significant **hypokalemia** (low potassium) affects cardiac and muscular function, it is **less commonly a direct cause of seizures** or status epilepticus compared to sodium imbalances. - Severe hypokalemia can impact neuronal excitability but primarily causes **muscle weakness** and **cardiac arrhythmias**. *Hyperkalemia* - **Hyperkalemia** (high potassium) primarily affects **cardiac conduction** and neuromuscular function, leading to **bradycardia** or **cardiac arrest**. - It is **not typically associated with seizures** or status epilepticus in children. *Hypernatremia* - **Hypernatremia** (high sodium) indicates a relative water deficit, leading to cell shrinkage and potentially **intracranial hemorrhage** or **thrombosis**. - While severe hypernatremia can cause neurological symptoms like **lethargy** or **coma**, it is **less commonly a direct cause of status epilepticus** compared to hyponatremia.
Question 6: A pediatric patient presents with a 45-minute history of continuous convulsions. The senior resident (SR) recommends IV lorazepam, but the junior resident (JR) is unable to secure IV access. What is the next best step in management?
- A. Rectal diazepam (Correct Answer)
- B. Intramuscular phenobarbital
- C. Intramuscular midazolam
- D. IV phenytoin
Explanation: ***Rectal diazepam*** - Rectal diazepam is an **effective first-line alternative** when IV access cannot be obtained in status epilepticus - It has a **rapid onset of action** (within 2-5 minutes) and can be easily administered in emergency settings - **Widely available** and part of established pediatric seizure protocols globally - Both rectal diazepam and IM midazolam are acceptable alternatives per current guidelines *Intramuscular midazolam* - IM midazolam is **equally effective** and increasingly preferred in many modern protocols when IV access is unavailable - The RAMPART trial demonstrated **faster seizure cessation** with IM midazolam compared to rectal diazepam in prehospital settings - **Both IM midazolam and rectal diazepam** are considered first-line alternatives per WHO and major pediatric emergency guidelines - Either option is appropriate depending on local protocols and availability *Intramuscular phenobarbital* - Phenobarbital has a **slower onset of action** when given intramuscularly (15-30 minutes) - Typically reserved for **refractory status epilepticus** or as a second-line agent after benzodiazepines have failed - Not preferred as an immediate alternative to IV lorazepam *IV phenytoin* - IV phenytoin **requires IV access**, which is specifically unavailable in this scenario - It is a second-line antiepileptic for status epilepticus, used after benzodiazepines - Requires **cardiac monitoring** due to risk of hypotension and arrhythmias
Question 7: According to current AAP guidelines, which of the following scenarios would be considered a relative indication for continuous antiepileptic prophylaxis in febrile seizures (though still generally not recommended)?
- A. 3 or more febrile seizures in 6 months
- B. Febrile seizures lasting more than 30 minutes (Correct Answer)
- C. 6 or more febrile seizures in 1 year
- D. Febrile seizures requiring pharmacotherapy to control seizures.
Explanation: **Febrile Seizure Prophylaxis - AAP Guidelines** According to current American Academy of Pediatrics (2011) guidelines, **continuous anticonvulsant prophylaxis is generally NOT recommended** for children with febrile seizures due to unfavorable risk-benefit ratio. However, among all scenarios, if any were to be considered (historically or in exceptional circumstances), it would be: ***Febrile seizures lasting more than 30 minutes*** - **Prolonged febrile seizures** (>30 minutes) represent the most severe form of complex febrile seizures - This is the scenario with highest risk of recurrence and potential complications - Historically, this was considered in older guidelines as a possible indication - **Current guidelines**: Even for prolonged febrile seizures, continuous prophylaxis is generally not recommended due to medication side effects - **Acute management**: Benzodiazepines for seizures >5 minutes; possible rescue medication prescription for home use - The risk-benefit still favors avoiding continuous prophylaxis in most cases **Why continuous prophylaxis is NOT recommended:** - **Side effects**: Phenobarbital (hyperactivity, cognitive impairment), Valproate (hepatotoxicity, teratogenicity) - **Ineffective**: Does not prevent epilepsy development - **Unnecessary**: Febrile seizures are benign and don't cause brain damage - **Poor compliance**: Long-term medication adherence is difficult **Analysis of other options:** *3 or more febrile seizures in 6 months* - Recurrence frequency alone is NOT an indication for prophylaxis - Simple febrile seizures, even if recurrent, have excellent prognosis - Parent education and fever management are appropriate *6 or more febrile seizures in 1 year* - Even very frequent febrile seizures do not warrant continuous prophylaxis - Focus remains on reassurance and supportive care - No change in long-term neurological outcome *Febrile seizures requiring pharmacotherapy to control seizures* - Acute pharmacotherapy (benzodiazepines) for active seizures is standard care - This does NOT indicate need for continuous prophylaxis - Rescue medications (diazepam rectal gel) may be prescribed for home use **Clinical Approach:** - Educate parents about benign nature of febrile seizures - Provide fever management strategies - Consider rescue benzodiazepines for select high-risk cases - Avoid continuous anticonvulsant prophylaxis
Question 8: Post-mortem caloricity is not seen in which of the following conditions?
- A. Pontine haemorrhage
- B. Bacteremia
- C. Status epilepticus
- D. Post-mortem glycogenolysis (Correct Answer)
Explanation: ***Post-mortem glycogenolysis*** - **Post-mortem glycogenolysis** is a **normal biochemical process** that occurs after death, involving the breakdown of glycogen in tissues. - It is **NOT a pre-death pathological condition** and does not cause the body temperature to rise after death. - **Post-mortem caloricity** occurs due to ante-mortem conditions with intense metabolic activity or thermoregulatory dysfunction, not from normal post-mortem biochemical changes. - This is the **correct answer** as it does NOT cause post-mortem caloricity. *Pontine haemorrhage* - **Pontine haemorrhage** causes damage to the **thermoregulatory centers** in the brainstem. - This leads to dysregulation and **uncontrolled heat generation**, resulting in hyperthermia. - The elevated metabolic state can persist briefly after death, causing **post-mortem caloricity**. *Bacteremia* - **Bacteremia** and **sepsis** trigger a massive **inflammatory response** with increased metabolic activity. - The heightened metabolic state generates significant heat before and immediately after death. - This contributes to elevated body temperature observed as **post-mortem caloricity**. *Status epilepticus* - **Status epilepticus** involves **prolonged, intense muscle contractions** and widespread neuronal activity. - This extreme metabolic demand generates substantial heat through continuous muscle activity. - The heat generation can persist briefly post-mortem, leading to **post-mortem caloricity**.
Question 9: Which is not used in status epilepticus?
- A. Lorazepam
- B. Phenytoin
- C. Phenobarbitone
- D. Metformin (Correct Answer)
Explanation: ***Metformin*** - **Metformin** is an **oral hypoglycemic agent** used to treat **type 2 diabetes mellitus** and has no role in the management of seizures or status epilepticus. - Its primary mechanism involves decreasing **hepatic glucose production** and improving **insulin sensitivity**. *Lorazepam* - **Lorazepam** is a first-line treatment for **status epilepticus** due to its rapid onset of action and efficacy in terminating seizures. - It enhances the effect of **GABA** (gamma-aminobutyric acid) at the GABA-A receptor, leading to neuronal hyperpolarization and reduced excitability. *Phenytoin* - **Phenytoin** is a common second-line agent used in status epilepticus, administered after benzodiazepines, to maintain seizure control. - It works by blocking **voltage-gated sodium channels**, thereby stabilizing neuronal membranes and preventing repetitive firing. *Phenobarbitone* - **Phenobarbitone** (phenobarbital) is an effective antiepileptic drug, often considered as a second or third-line agent in status epilepticus, especially when other treatments fail. - It acts primarily by enhancing the activity of **GABA** at the GABA-A receptor, similar to benzodiazepines, but with a longer duration of action.
Question 10: Among the neurological manifestations, acute lead poisoning in children can present with:
- A. Cerebellar ataxia
- B. Status epilepticus (Correct Answer)
- C. Focal neurological deficits
- D. ICP and papilledema
Explanation: ***Status epilepticus*** - **Status epilepticus** is a severe and life-threatening neurological emergency in acute lead poisoning in children, representing the most critical manifestation requiring immediate intervention. - This arises from severe **neurotoxicity** and cerebral edema induced by lead, leading to uncontrolled seizure activity. - Status epilepticus indicates profound CNS involvement and requires urgent management with chelation therapy and seizure control. *Cerebellar ataxia* - While lead poisoning can cause neurological dysfunction, **cerebellar ataxia** is not a typical presentation of acute lead poisoning in children. - Ataxia is more commonly associated with **chronic lead exposure** or other specific neurological conditions affecting the cerebellum. *Focal neurological deficits* - **Focal neurological deficits** are less common in acute lead poisoning, which typically presents with **diffuse** rather than localized neurological symptoms. - While focal seizures or hemiparesis can occasionally occur, the predominant pattern is generalized encephalopathy. *ICP and papilledema* - **Increased intracranial pressure (ICP)** and **papilledema** are indeed significant features of acute lead encephalopathy and reflect severe cerebral edema. - However, among the acute neurological manifestations, **status epilepticus** represents the most acute life-threatening emergency requiring immediate intervention, making it the best answer in this clinical context.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free